[Expert recommendations for the prevention and control of pediatric respiratory syncytial virus infections in China (2023 edition)].

Respiratory syncytial virus (RSV) is one of the major pathogens responsible for acute lower respiratory tract infections (LRTI) and hospitalizations in children. It is also the primary viral pathogen causing lower respiratory tract infections in children under 5 years old, posing a significant threat to child health. In order to advance RSV prevention and control efforts and comprehensively explore RSV disease burden, epidemiological patterns, development and regulation of preventive and therapeutic measures, as well as the formulation of related strategies for prevention and control, the Editorial Board of the Chinese Medical Association Chinese Medical Journal convened the "Chinese Respiratory Syncytial Virus Forum" in December 2022. Participating experts, focusing on the current research status and developmental requirements concerning respiratory syncytial virus, engaged in discussions and exchanges, culminating in the formulation of expert recommendations for the prevention and control of pediatric respiratory syncytial virus infections in China: (1) Strengthen research on RSV epidemiological characteristics and disease burden; (2) Establish a collaborative, multi-departmental, and multi-disciplinary approach for sustained, multicenter, long-term monitoring; (3) Emphasize innovation, research, development, and implementation of vaccines, monoclonal antibodies, and diagnostic methods; (4) Propel the formulation and implementation of RSV immunoprophylaxis strategies; (5) Coordinate and allocate pediatric medical and health resources rationally to prevent nosocomial infections.